These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28176473)

  • 41. [C3 glomerulopathy].
    Chauvet S; Servais A; Frémeaux-Bacchi V
    Nephrol Ther; 2014 Apr; 10(2):78-85. PubMed ID: 24508002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C3 glomerulonephritis associated with monoclonal gammopathy: a retrospective case series study from a single institute in China.
    Zhang X; Yu XJ; Li DY; Wang SX; Zhou FD; Zhao MH
    Ren Fail; 2021 Dec; 43(1):1437-1445. PubMed ID: 34658305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.
    Segarra A; Amoedo ML; Martinez Garcia JM; Pons S; Praga M; Garcia EI; Alonso JC; Gascó JM; Pou L; Piera L
    Nephrol Dial Transplant; 2007 May; 22(5):1351-60. PubMed ID: 17311833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Rare Case of C3 Glomerulonephritis Presenting as Pulmonary Renal Syndrome.
    Mederos G; Patel H; Hapuarachchi M; Nair R; Ciobanu D; Madhrira M
    HCA Healthc J Med; 2020; 1(6):485-488. PubMed ID: 37427045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and treatment of C3 glomerulopathy.
    Nester CM; Smith RJ
    Clin Nephrol; 2013 Dec; 80(6):395-403. PubMed ID: 23993166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.
    Coltoff A; Bomback A; Shirazian S; Lentzsch S; Bhutani D
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e674-e677. PubMed ID: 34023209
    [No Abstract]   [Full Text] [Related]  

  • 47. C3 glomerulopathies. A new perspective on glomerular diseases.
    Rabasco-Ruiz C; Huerta-Arroyo A; Caro-Espada J; Gutiérrez-Martínez E; Praga-Terente M
    Nefrologia; 2013; 33(2):164-70. PubMed ID: 23511752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Benefits of mycophenolate mofetil in non-transplant kidney diseases].
    Parotte MC; Bovy C; Krzesinski JM
    Rev Med Suisse; 2007 Aug; 3(122):1899-901, 1903-5. PubMed ID: 17896664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic tests and treatment options in glomerular disease: 2014 update.
    Hogan J; Mohan P; Appel GB
    Am J Kidney Dis; 2014 Apr; 63(4):656-66. PubMed ID: 24239051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy.
    Zhang Y; Shao D; Ricklin D; Hilkin BM; Nester CM; Lambris JD; Smith RJ
    Immunobiology; 2015 Aug; 220(8):993-8. PubMed ID: 25982307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study.
    Dimkovic N; Jovanovic D; Kovacevic Z; Rabrenovic V; Nesic V; Savin M; Mitic B; Ratkovic M; Curic S; Mitic I; Pljesa S; Perunicic-Pekovic G; Marinkovic J; Popovic J; Vujic D
    Nephron Clin Pract; 2009; 111(3):c189-96. PubMed ID: 19194109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C4d as a Diagnostic Tool in Proliferative GN.
    Sethi S; Nasr SH; De Vriese AS; Fervenza FC
    J Am Soc Nephrol; 2015 Nov; 26(11):2852-9. PubMed ID: 25991041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C3 glomerulopathy masquerading as acute postinfectious glomerulonephritis.
    Sandhu G; Bansal A; Ranade A; Jones J; Cortell S; Markowitz GS
    Am J Kidney Dis; 2012 Dec; 60(6):1039-43. PubMed ID: 22770945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy.
    Bharati J; Tiewsoh K; Kumar A; Nada R; Rathi M; Gupta KL; Kohli HS; Jha V; Ramachandran R
    Clin Kidney J; 2019 Aug; 12(4):483-487. PubMed ID: 31384438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.
    Ali A; Schlanger L; Nasr SH; Sethi S; Gorbatkin SM
    Am J Kidney Dis; 2016 Mar; 67(3):479-82. PubMed ID: 26704376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?
    Ciocchini M; Musso CG
    Int Urol Nephrol; 2018 Jul; 50(7):1365-1366. PubMed ID: 29808447
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
    Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
    Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C3 glomerulopathy: A new complement-based entity.
    de Lorenzo A; Tallón S; Hernández-Sevillano B; de Arriba G
    Rev Clin Esp (Barc); 2014; 214(5):266-74. PubMed ID: 24576419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
    Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.